GST HG131
Alternative Names: GST-HG131Latest Information Update: 21 Feb 2024
Price :
$50 *
At a glance
- Originator Fujian Cosunter Pharmaceutical
- Class Antivirals; Small molecules
- Mechanism of Action Hepatitis B surface antigen expression inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Hepatitis B
Most Recent Events
- 29 Dec 2023 Phase-II clinical trials in Hepatitis B in China (PO) (NCT06263959)
- 28 Sep 2023 No recent reports of development identified for phase-I development in Hepatitis-B(In volunteers) in China (PO, Tablet)
- 18 Aug 2020 Phase-I clinical trials in Hepatitis B (In volunteers) in China (PO) (NCT04499443)